Stelios Papadopoulos - May 15, 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
May 15, 2025
Transactions value $
-$885,779
Form type
4
Date filed
5/16/2025, 08:57 PM
Previous filing
Apr 30, 2025
Next filing
May 30, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PAPADOPOULOS STELIOS Director C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA /s/ Nina Ayer, Attorney in Fact 2025-05-16 0001202098

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $408K +20.6K +1.61% $19.77 1.3M May 15, 2025 Direct F1
transaction EXEL Common Stock Sale -$915K -20.6K -1.59% $44.35 1.28M May 15, 2025 Direct F1
transaction EXEL Common Stock Options Exercise $325K +15.9K +1.24% $20.50 1.3M May 15, 2025 Direct F1
transaction EXEL Common Stock Sale -$704K -15.9K -1.23% $44.35 1.28M May 15, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -20.6K -100% $0.00 0 May 15, 2025 Common Stock 20.6K $19.77 Direct F2
transaction EXEL Option (right to buy) Options Exercise $0 -15.9K -100% $0.00 0 May 15, 2025 Common Stock 15.9K $20.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2 The option, representing the right to purchase a total of 20,634 shares of Common Stock, became fully exercisable on May 23, 2019.
F3 The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018.